Showing posts with label synthetic biology. Show all posts
Showing posts with label synthetic biology. Show all posts

Sunday, 11 April 2010

Is xenobiology becoming a reality?

One of the goals in synthetic biology is to design an orthogonal chromosome different from DNA and RNA, termed XNA for xeno nucleic acids. Xenobiological systems like XNA are ‘‘invisible’’ to natural biological systems, which means they could be the ultimate biosafety tool.

Read more about it in the recently published Open Access Paper:
Schmidt M. 2010. Xenobiology: A new form of life as the ultimate biosafety tool. BioEssays Vol.32(4): 322-331



For further information see also:

Synbiosafe Trailer from Camillo on Vimeo.

You can guess that I just couldn't resist moving to this topic after referring to the xenomorphs from the Alien series in the previous post. In this case engineering dictates that, unlike the science fiction, there is no evolution through interaction (i.e. using other lifeforms as "hosts") with the "natural" environment. But what to make of this piece of understatement from Schmidt's article?: "is it necessary to prohibit any activities that actively try to undermine the specifications mentioned above? i.e. similar to prohibiting R & D that aims at developing new offensive bioweapons?" Gee Markus, what do you think? Why the rhetorical stance? Cat got your tongue?

Make no mistake about it then, this debate will assume increasing importance. If the precautionary principle of post-normal science prominently features at this stage, how difficult will it be to maintain given the amounts of money needed to fund it into the future? Compromises might be introduced sooner than we would like (a potential for military applications will be only one facet of this). "Bring on more debate", is what I say.

Synthetic Biology

the technoscience and its societal consequences

Schmidt, M.; Kelle, A.; Ganguli-Mitra, A.; Vriend, H. (Eds.)

2010, VIII, 186 p., Hardcover

ISBN: 978-90-481-2677-4

Usually dispatched within 3 to 5 business days

119,95 €
  • About this book

Synthetic biology is becoming one of the most dynamic new fields of biology, with the potential to revolutionize the way we do biotechnology today. By applying the toolbox of engineering disciplines to biology, a whole set of potential applications become possible ranging very widely across scientific and engineering disciplines. Some of the potential benefits of synthetic biology, such as the development of low-cost drugs or the production of chemicals and energy by engineered bacteria are enormous. There are, however, also potential and perceived risks due to deliberate or accidental damage. Also, ethical issues of synthetic biology just start being explored, with hardly any ethicists specifically focusing on the area of synthetic biology. This book will be the first of its kind focusing particularly on the safety, security and ethical concerns and other relevant societal aspects of this new emerging field. The foreseen impact of this book will be to stimulate a debate on these societal issues at an early stage. Past experiences, especially in the field of GM-crops and stem cells, have shown the importance of an early societal debate. The community and informed stakeholders recognize this need, but up to now discussions are fragmentary. This book will be the first comprehensive overview on relevant societal issues of synthetic biology, setting the scene for further important discussions within the scientific community and with civil society.

Content Level » Research

Related subjects » Biomedical Sciences - Biotechnology - Medicine - Production & Process Engineering - R&D / Technology Policy

Table of Contents

1. Introduction, Markus Schmidt; 2. That Was the Synthetic Biology That Was, Luis Campos; 3. An Introduction to Synthetic Biology, Carolyn M.C. Lam, Miguel Godinho, Vítor A.P. Martins dos Santos; 4. Computational Design in Synthetic Biology, Maria Suarez, Guillermo Rodrigo, Javier Carrera, Alfonso Jaramillo; 5. The Ethics of Synthetic Biology, Anna Deplazes, Agomoni Ganguli-Mitra, Nikola Biller-Andorno; 6. Do I understand what I can create?, Markus Schmidt; 7. Security Issues Related to Synthetic Biology, Alexander Kelle; 8. The Intellectual Commons and Property in Synthetic Biology, Kenneth A. Oye, Rachel Wellhausen; 9. Governing Synthetic Biology: processes and outcomes, Joyce Tait; 10. Synthetic Biology and the Role of Civil Society Organisatons, Dirk Stemerding, Huib de Vriend, Bart Walhout, Rinie van Est; 11. Summary and Calculations, Alexander Kelle; Index

Wednesday, 10 December 2008

"Useless Eaters" & Synthetic Biology

Francis Galton, who coined the word "eugenics" in 1865, envisioned a system of artificial selection whereby society would permit people with "desirable" qualities to have children (positive eugenics), while individuals with "undesirable" traits would be prevented from having children (negative eugenics). For a thirty-year span, between 1900 and 1929, the eugenics movement captured the attention of America’s leading reformers, academicians, professionals, and political leaders, including industrialist John Kellogg, inventor Alexander Graham Bell (who advocated sterilization of the deaf and the dismantling of deaf people's culture), and women’s rights advocate Margaret Sanger. By the early 1930s, however, the climate that had been receptive to eugenics in America had broken down. Several factors led to the downfall of the American eugenics movement, including the Stock Market crash of 1929, scientific discoveries in the new field of genetics, and public mistrust of the restrictions on marriage and childrearing that selective breeding required. The rise of Nazism in the 1930s completely discredited the eugenics movement for the next four decades. Eugenics re-emerged as a scientific endeavor—and as a social issue—following the advent of biotechnology in the early 1970s, when bacterial DNA from two different species was combined by two researchers, Stanley Cohen of Stanford University and Herbert Boyer of the University of California. Although the Cohen-Boyer experiment involved rDNA technology, it demonstrated the possibility of direct gene manipulation, and scientists rapidly saw the potential use of the technique in human-gene therapy.
Human-gene therapy is a procedure in which defective (faulty) copies of a gene are replaced with non-defective (functional) copies. For example, Severe Combined Immuno-Deficiency syndrome (SCID) is a genetic disorder caused by mutations in a single gene, adenosine deaminase (ADA), which is on human chromosome 20. Individuals who possess two defective copies of this gene cannot make the protein adenosine deaminase; thus, they do not possess a functioning immune system. Gene therapy treatments for SCID involve putting non-defective copies of ADA into the DNA of an affected individual’s bone cells, allowing them to make adenosine deaminase. Gene therapy can either be used to treat individuals who already have a genetic disorder (somatic cell therapy), or to correct genes in sperm, eggs, or embryonic cells (germ-line therapy). Germ-line therapy gives scientists the ability to change an individual’s genetic makeup before they are born, or even conceived.
The treatment of highly deleterious genetic disorders does not create public anxiety about gene therapy. Cosmetic gene therapy, however, conjures up images of a new eugenics because it not only allows healthy individuals to change their physical appearance and/or behaviors through gene manipulation, but allows these changes to be passed down to future generations. Molecular biologists have already isolated the genes that code for many physical traits, such as skin color, baldness, and stature. In addition, some scientists claim to have found genes that code for complex behaviors, such as shyness and homosexuality. Although many of these arguments have been shown to be fallacious, popular press coverage has contributed to the growing public belief that behaviors are genetically determined. Even granting the dubious character of some of these more sweeping claims, it is almost certainly the case that within the next few decades our increasing knowledge of human genetics, combined with germ-line therapy, will enable us to produce custom-designed genetic individuals.

Inevitably, when the bioethical issues surrounding eugenics are discussed, one of the first images conjured up is of the blond-haired, blue-eyed, light-skinned "Aryan race" as envisioned during the Nazi eugenics program (note Flash Player required to view Mark Mostert's site). The new eugenics, however, will encompass not only such physical characteristics as skin, eye, and hair color, but will potentially include genetic manipulation of behaviors and personality. Thus, anxiety over a new eugenics is predicated upon the belief that all human traits are genetically determined in the first place. Genetic determinism, which is also known as bio-determinism or genetic essentialism, is the belief that human behavior, personality, and physical appearance are determined exclusively by a person’s genetic makeup. Genetic determinism is a reductionist ideology in that it seeks to explain a complex whole (a human being) in terms of its component parts (individual genes). Richard Lewontin, Steven Rose, and Leon Kamin, biologists and longtime critics of genetic determinism, summarize the basic ideology as follows:
Biological [genetic] determinists ask, in essence, Why are individuals as they are? Why do they do what they do? And they answer that human lives and actions are inevitable consequences of the biochemical properties of the cells that make up the individual; and these characteristics are in turn uniquely determined by the constituents of the genes possessed by each individual. Ultimately, all human behavior—hence all human society—is governed by a chain of determinants that runs from the gene to the individual to the sum of the behaviors of all individuals.
Considering that the goal of eugenics is to improve humanity through genetic manipulation, it is clear that a eugenics program cannot succeed unless genetic determinism is accepted as the true state of the world. Gene therapy will lead to a new eugenics only if society follows to some degree a genetic-determinist ideology.

But for this ideology to take hold, it would have to be a symptom of a very powerful logic of commodification. Some sense of what will be at stake is discernible from the following debate, in which Jim Thomas questions the assumption that a movement to "open source" will automatically provide the needed safeguard against corporate oligopolies and militarization. Thomas draws some much needed lessons from history to encourage greater public accountability.


Saturday, 9 August 2008

Gregor Wolbring

In an earlier post I wondered aloud whether there were any telling differences between the ethical approaches to synthetic biology used by Gregor Wolbring and Paul Rabinow:
http://whoeverfightsmonsters-nhuthnance.blogspot.com/2008/07/on-assembly-of-things-ramifying.html

I'm happy to report that I now have a response from Gregor, on the understanding that it may be posted on this blog for the benefit of others. If I have at all misconstrued Gregor's tacit approval of posting here, I will remove it upon his request. My question was general as I wanted a starting point to get to grips with the concept of "ableism" Wolbring is associated with:
HERE IS WHAT GREGOR WROTE:

Ok here my take. This is a cleaned up version. It is NOT a general critique of Rabinow. That also would be beside the point. I do not disagree with many of the sentiments. I just feel for them to be useful they have to be embedded into a totally different social structure and discours.

THe main sentence from how you quote Rabinow is "The question of what constitutes a good life today, and the contribution of the bio-sciences to that form of life must be posed and re-posed."

I agree with the sentiment of that quote and I wrote on that for example in my bookchapter Wolbring, (2003), "Confined to Your Legs," in A. Lightman, D. Sarewitz,and C. Desser (eds.), Living with the Genie: Essays on Technology and the Quest for Human Mastery (Washington, DC: Island Press). ISBN: 1-55963-419-7

However that is not the whole story.
Depending whom one talks to will lead to totally different answers as to what constitutes a good life and depending on how one answers that question one gets totally different answers to the question what the contribution of the biosciences to that form of life is and could be.

I cover in my recent writings a lot the concept of ability governance. (see for example here Wolbring (2008) "Is there an end to out-able? Is there an end to the rat race for abilities?" http://journal.media-culture.org.au/index.php/mcjournal/article/viewArticle/57 for Journal: Media and Culture, Volume 11, Issue 3, July. 2008 or here Wolbring (2008) Why NBIC? Why human performance enhancement? European Journal of Social Science Research, Vol 21,No.1,pp.25-40

What forms of ableism and favoritism of abilities one exhibits has a direct impact on how one defines and perceives what constitutes a good life, what the problems are that prevent the reaching of that good life and what solutions are thought out to deal with the 'problems'. The discourses around science and technology governance leave out many facets and subgroups of earth population and with that exhibits fairly homogenous take on acceptable forms of ableism and favoritism of abilities. The less diverse the reference group is, the easier it is to define a certain vision of the good life, the existing problems preventing one to reach it and the solutions for that problem.

Most of the science an technology governance discourse is about environmental and medical health issues. Social risk, social health issues are rarely raised by the proponent or opponents of a givens contested science and technology. And certain groups of earth populations are routinely excluded
Wolbring (2007) "Nano-Engagement: Some critical issues Journal of Health and Development (India)Vol. 3 No 1-2, pp. 9-29

In general how we govern science and technology and what science and technology we seek what is accepted and what is not is a direct result of what ableism's a given society is exhibiting and accepting and what abilities a given culture is seeking.

And of course as certain science and technolgy enable new abilities and ableisms the very appearance of certain science and technology will support certain new ableisms and favoritisms for certain abilities.


One other quote from how you quote Rabinow is “And ethics and science can play a mutually formative role”.
Again on the surface there is nothing wrong with such statement. However depending which ethics one uses changes quite a bit the nature of the formative role and what output the given ethics discourse generates.




Sunday, 27 July 2008

On the assembly of things: ramifying synthetic biology & nanotechnology

I have to rush this morning, so thought I'd briefly mention this engagement with topics I referred to earlier in a post on Gregor Wolbring. In this case though it is the renowned Foucauldian scholar Paul Rabinow and his associates, who not only link to resources on "nanotech & society", but also clarify their own approach in these terms:
"It explores “human practices”: the ethics and ontology of these two domains beyond the standard models of social implications, ELSI, or so-called Mode 2 Knowledge production....Ethics:We hold that bio-ethics, as frequently positioned in official settings, undervalues the extent to which ethics and science can play a mutually formative role.Although such work remains valuable for work on the problems it was constructed to deal with. Emergent things require new equipment. Such equipment is designed to contribute to a “flourishing existence” (eudaemonia). Eudaemonia should not be confused with technical optimization, as capacities are not already known.The question of what constitutes a good life today, and the contribution of the bio-sciences to that form of life must be posed and re-posed. We are persuaded that within collaborative structures biology, ethics and anthropology can orient practice to the flourishing as both telos and mode of operation."
What I'd like to be able to clarify then, as soon as possible, is the extent of the telling differences of this focus from Wolbring's work on "ableism" and Steve Fuller's on nanotechnology (previously referenced on this blog). I may get a chance to do so soon as Gregor has invited me to comment on his stuff, and Steve has asked if I'm interested in interviewing him about his new book on Intelligent Design and then posting it on this blog. I've got a lot of other things to get through next week as well, so I hope all of this can start to come together.